促凝血血小板活化促进静脉血栓形成
研究提出促凝血活化(PA)血小板促进静脉血栓形成的假说,发现深静脉血栓和肺栓塞患者循环及血栓中促凝血血小板升高,小鼠下腔静脉狭窄模型中促凝血活化亦增强;血小板特异性缺失PA关键通路的小鼠对低血流诱导的静脉血栓更具抵抗性,甲唑胺可减少血小板促凝血活性并减轻小鼠血栓形成而不影响创伤止血。
要点
- 深静脉血栓和肺栓塞患者循环及血栓中促凝血血小板水平升高。
- 小鼠下腔静脉狭窄静脉血栓中可检测到募集血小板的促凝血活化。
- 血小板特异性缺失亲环蛋白D或跨膜蛋白16F的小鼠对低血流诱导的静脉血栓更具抵抗性。
核心结论
- 血小板促凝血功能在静脉血栓形成中起重要作用,靶向血小板促凝血活化是预防静脉血栓栓塞症的新药理学策略。
研究设计与样本
- 研究纳入深静脉血栓和肺栓塞患者,检测循环及血栓中的促凝血血小板水平。
- 采用下腔静脉狭窄诱导小鼠深静脉血栓模型,检测静脉血栓中募集血小板的促凝血活化。
- 使用血小板特异性缺失亲环蛋白D和跨膜蛋白16F的小鼠评估对低血流诱导静脉血栓的抵抗性。
- 评估碳酸酐酶抑制剂甲唑胺对小鼠血小板促凝血活性和血栓形成的影响。
主要发现
- 深静脉血栓和肺栓塞患者循环及血栓中促凝血血小板水平升高。
- 小鼠下腔静脉狭窄所致深静脉血栓中可检测到募集血小板的促凝血活化,人肺栓塞血栓中亦检测到促凝血活化。
- 血小板特异性缺失亲环蛋白D或跨膜蛋白16F的小鼠对低血流诱导的静脉血栓更具抵抗性。
- 甲唑胺减少血小板促凝血活性并减轻小鼠血栓形成,且不影响创伤相关止血。
临床怎么用
- 原文结论指出靶向血小板促凝血活化是预防静脉血栓栓塞症的新药理学策略,未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Platelets are key players in cardiovascular disease, and platelet aggregation represents a central pharmacologic target, particularly in secondary prevention. However, inhibition of adenosine diphosphate and thromboxane signaling has low efficacy in preventing venous thromboembolism, necessitating the inhibition of the plasmatic coagulation cascade in this disease entity. Anticoagulation carries a significantly higher risk of bleeding complications, highlighting the need of alternative therapeutic approaches. We hypothesized that procoagulant activation (PA) of platelets promotes venous thrombus formation and that targeting PA could alleviate venous thrombosis. Here, we found elevated levels of procoagulant platelets in the circulation and in thrombi of patients with deep vein thrombosis (DVT) and pulmonary embolism, and in mice developing DVT following inferior vena cava stenosis. Furthermore, we detected PA of recruited platelets within murine venous thrombi and human pulmonary emboli. Mice with platelet-specific deficiency in central pathways of PA-cyclophilin D and transmembrane protein 16F-were more resistant toward low flow-induced venous thrombosis. Finally, we found that a clinically approved carbonic anhydrase inhibitor, methazolamide, reduced platelet procoagulant activity and alleviated murine thrombus formation without affecting trauma-associated hemostasis. These findings identify an essential role of platelet procoagulant function in venous thrombosis and delineate novel pharmacologic strategies targeting platelets in the prevention of venous thromboembolism.
引用
- Kaiser R, Dewender R, Mulkers M, et al. Procoagulant platelet activation promotes venous thrombosis. Blood. 2024. PMID: 39440970. doi:10.1182/blood.2024025476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。